Low-dose cyclosporine treatment for sight-threatening uveitis: Efficacy, toxicity, and tolerance

por Mathews, D, Mathews, John, Jones, N P
Publicado 2010

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardio...

por Home, P. D., Kahn, S. E., Jones, N. P., Noronha, D., Beck-Nielsen, H., Viberti, G.
Publicado 2010

Rosiglitazone RECORD study: glucose control outcomes at 18 months

por Home, P D, Jones, N P, Pocock, S J, Beck-Nielsen, H, Gomis, R, Hanefeld, M, Komajda, M, Curtis, P
Publicado 2007